Xenon Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MORTIMER IAN officer: PRESIDENT & CFO
 Common Stock 4,300 N/A N/A
Option
HAYDEN MICHAEL R director
 Common Shares 8,230 N/A N/A
Option
HAYDEN MICHAEL R director
 Stock Option (Right to Buy) 8,230 N/A N/A
Option
TARNOW MICHAEL M director
 Stock Option (Right to Buy) 1,543 N/A N/A
Option
TARNOW MICHAEL M director
 Common Shares 1,543 N/A N/A
Option
ROBIN SHERRINGTON officer: EVP, Strategy & Innova..
 Stock Option (Right to Buy) 411 N/A N/A
Option
ROBIN SHERRINGTON officer: EVP, Strategy & Innova..
 Common Shares 411 N/A N/A
Option
AZAB MOHAMMAD director
 Stock Option (Right to Buy) 2,469 N/A N/A
Option
AZAB MOHAMMAD director
 Common Shares 2,469 N/A N/A
Option
HOLLER FRANK A director
 Common Shares 2,057 N/A N/A
Option
HOLLER FRANK A director
 Stock Option (Right to Buy) 2,057 N/A N/A
Option
PATOU GARY director
 Stock Option (Right to Buy) 3,497 N/A N/A
Option
PATOU GARY director
 Common Shares 3,497 N/A N/A
Option
TARNOW MICHAEL M director
 Common Shares 5,041 N/A N/A
Option
TARNOW MICHAEL M director
 Stock Option (Right to Buy) 5,041 N/A N/A
Sale
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Common Shares 12,000 N/A N/A
Sale
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Common Shares 4,000 N/A N/A
Sale
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Common Shares 6,149 N/A N/A
Option
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Common Shares 30,388 N/A N/A
Option
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Stock Option (Right to Buy) 12,284 N/A N/A
Option
PIMSTONE SIMON N. director, officer: CEO
 Common Shares 20,576 N/A N/A
Option
ROBIN SHERRINGTON officer: EVP, Strategy & Innova..
 Common Shares 3,085 N/A N/A
Option
PIMSTONE SIMON N. director, officer: CEO
 Stock Option (Right to Buy) 5,144 N/A N/A
Option
HOLLER FRANK A director
 Common Shares 2,057 N/A N/A
Option
HOLLER FRANK A director
 Stock Option (Right to Buy) 2,057 N/A N/A
Option
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Stock Option (Right to Buy) 1,028 N/A N/A
Option
GOLDBERG Y. PAUL officer: SVP, Clinical Developm..
 Common Shares 3,085 N/A N/A
Option
ROBIN SHERRINGTON officer: EVP, Strategy & Innova..
 Stock Option (Right to Buy) 1,028 N/A N/A
Option
TARNOW MICHAEL M director
 Common Shares 1,543 N/A N/A
Option
TARNOW MICHAEL M director
 Stock Option (Right to Buy) 1,543 N/A N/A
Option
HAYDEN MICHAEL R director
 Stock Option (Right to Buy) 5,144 N/A N/A
Option
HAYDEN MICHAEL R director
 Common Shares 5,144 N/A N/A
Option
AZAB MOHAMMAD director
 Stock Option (Right to Buy) 2,469 N/A N/A
Option
TARNOW MICHAEL M director
 Stock Option (Right to Buy) 5,041 N/A N/A
Option
HAYDEN MICHAEL R director
 Stock Option (Right to Buy) 5,144 N/A N/A
Option
TARNOW MICHAEL M director
 Common Shares 5,041 N/A N/A
Option
HAYDEN MICHAEL R director
 Common Shares 5,144 N/A N/A
Option
AZAB MOHAMMAD director
 Common Shares 2,469 N/A N/A
Option
PATOU GARY director
 Common Shares 3,497 N/A N/A
Option
PATOU GARY director
 Stock Option (Right to Buy) 3,497 N/A N/A

Showing 250 to 290 of 290 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: